Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Approximately 70% of breast cancers are HR-positive/HER2 negative. While activating ESR1 mutations are rare at the time of ...

Thousands of islanders are set to walk across Guernsey next month, to mark 10 years of a breast cancer charity's sunset walks ...

Q. My doctor prescribed raloxifene when I was in my 50s because my mother had died of breast cancer. She believed this drug ...

CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line ...

The data may change how patients are treated following a diagnosis for advanced triple-negative breast cancer, one expert ...

Stephanie Walker was diagnosed with metastatic breast cancer (MBC) nearly a decade ago — an experience she says transformed ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Compared with digital mammography, 3D mammography (or tomosynthesis) reduces recall rates and improves specificity in women ...

AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a ...

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic ...

A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found.